Target Gene Table ▼
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46001397BKPyvENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS10003622HBVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS10012046HBVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS10008929HBVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS10017508HBVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS10017509HBVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS10017510HBVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS10017511HBVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS10017512HBVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS10021570HBVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TCGA Plot Options ▼
Drug Information ▼
GeneNR3C2
DrugBank IDDB00393
Drug NameNimodipine
Target IDBE0000668
UniProt IDP08235
Regulation Typeantagonist
PubMed IDs18250364
CitationsDietz JD, Du S, Bolten CW, Payne MA, Xia C, Blinn JR, Funder JW, Hu X: A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity. Hypertension. 2008 Mar;51(3):742-8. doi: 10.1161/HYPERTENSIONAHA.107.103580. Epub 2008 Feb 4.
GroupsApproved; Investigational
Direct ClassificationDihydropyridinecarboxylic acids and derivatives
SMILESCOCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
PathwaysNimodipine Action Pathway
PharmGKBPA450633
ChEMBLCHEMBL1428